• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有22q11.2缺失综合征的成年人肥胖症

Obesity in adults with 22q11.2 deletion syndrome.

作者信息

Voll Sarah L, Boot Erik, Butcher Nancy J, Cooper Samantha, Heung Tracy, Chow Eva W C, Silversides Candice K, Bassett Anne S

机构信息

MD Program, University of Toronto, Faculty of Medicine, Toronto, Ontario, Canada.

Clinical Genetics Research Program and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

出版信息

Genet Med. 2017 Feb;19(2):204-208. doi: 10.1038/gim.2016.98. Epub 2016 Aug 18.

DOI:10.1038/gim.2016.98
PMID:27537705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5292049/
Abstract

PURPOSE

To characterize the prevalence of and contributing factors to adult obesity in the most common recurrent copy-number variation (CNV), 22q11.2 deletion, given that other rare CNVs are known to have obesity phenotypes.

METHODS

In 207 adults with 22q11.2 deletion syndrome (22q11.2DS), we used available height and weight measurements to calculate body mass index (BMI) and recorded associated factors that could play a role in obesity. We used the maximum BMI per subject and logistic regression to test a model predicting obesity class.

RESULTS

The prevalence of obesity (BMI ≥30) in 22q11.2DS (n = 90, 43.5%; at median age of 26.7 years) was significantly greater than for Canadian norms (odds ratio (OR) 2.30, 95% confidence interval (CI) = 1.74-3.02, P < 0.0001), even after excluding individuals with a history of antipsychotic use. The regression model was significant (P < 0.0001). Psychotropic medication use and age, but not sex or presence of intellectual disability, were associated with higher obesity level. Ten (4.8%) individuals were diagnosed with type 2 diabetes at a median age of 39.5 years; the prevalence was higher in those with obesity (P < 0.01).

CONCLUSION

The results suggest that adult obesity is related to the 22q11.2 deletion. The findings expand the potential genetic causes of obesity and have important implications for management of 22q11.2DS.Genet Med 19 2, 204-208.

摘要

目的

鉴于已知其他罕见的拷贝数变异(CNV)具有肥胖表型,本研究旨在描述最常见的复发性拷贝数变异22q11.2缺失中成人肥胖的患病率及其影响因素。

方法

在207例患有22q11.2缺失综合征(22q11.2DS)的成人中,我们利用现有的身高和体重测量数据计算体重指数(BMI),并记录可能与肥胖有关的因素。我们采用每位受试者的最高BMI值和逻辑回归分析来检验预测肥胖等级的模型。

结果

22q11.2DS患者(n = 90,43.5%;中位年龄26.7岁)的肥胖患病率(BMI≥30)显著高于加拿大正常水平(优势比(OR)2.30,95%置信区间(CI)= 1.74 - 3.02,P < 0.0001),即使排除有抗精神病药物使用史的个体后仍是如此。回归模型具有统计学意义(P < 0.0001)。使用精神药物和年龄与较高的肥胖水平相关,而性别和智力残疾的存在与肥胖水平无关。10例(4.8%)个体在中位年龄39.5岁时被诊断为2型糖尿病;肥胖患者中的患病率更高(P < 0.01)。

结论

结果表明成人肥胖与22q11.2缺失有关。这些发现扩展了肥胖的潜在遗传原因,对22q11.2DS的管理具有重要意义。《遗传医学》19卷2期,204 - 208页。

相似文献

1
Obesity in adults with 22q11.2 deletion syndrome.患有22q11.2缺失综合征的成年人肥胖症
Genet Med. 2017 Feb;19(2):204-208. doi: 10.1038/gim.2016.98. Epub 2016 Aug 18.
2
Obesity and metabolic syndrome in adults with a 22q11.2 microdeletion.伴有22q11.2微缺失的成年人中的肥胖与代谢综合征
Int J Obes (Lond). 2025 Apr;49(4):642-648. doi: 10.1038/s41366-024-01685-2. Epub 2024 Nov 30.
3
The role of 22q11.2 deletion syndrome in the relationship between congenital heart disease and scoliosis.22q11.2 缺失综合征在先天性心脏病与脊柱侧凸关系中的作用。
Spine J. 2020 Jun;20(6):956-963. doi: 10.1016/j.spinee.2020.01.006. Epub 2020 Jan 18.
4
Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.22q11.2缺失综合征中精神分裂症的罕见全基因组拷贝数变异与表达
Am J Psychiatry. 2017 Nov 1;174(11):1054-1063. doi: 10.1176/appi.ajp.2017.16121417. Epub 2017 Jul 28.
5
Adult Height, 22q11.2 Deletion Extent, and Short Stature in 22q11.2 Deletion Syndrome.22q11.2 缺失综合征中的成人身高、22q11.2 缺失程度与身材矮小。
Genes (Basel). 2022 Nov 5;13(11):2038. doi: 10.3390/genes13112038.
6
Phenotypic traits and family history in patients with 22q11.2 deletion syndrome and generalized epilepsy: A multicenter case-control study.22q11.2缺失综合征与全身性癫痫患者的表型特征和家族史:一项多中心病例对照研究
Epilepsia. 2025 Mar;66(3):859-869. doi: 10.1111/epi.18220. Epub 2024 Dec 24.
7
Fetal growth and gestational factors as predictors of schizophrenia in 22q11.2 deletion syndrome.胎儿生长和妊娠因素作为22q11.2缺失综合征中精神分裂症的预测指标
Genet Med. 2016 Apr;18(4):350-5. doi: 10.1038/gim.2015.84. Epub 2015 Jun 18.
8
Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications.早发性帕金森病与 22q11.2 缺失综合征的关联:一种新型帕金森病的遗传形式的鉴定及其临床意义。
JAMA Neurol. 2013 Nov;70(11):1359-66. doi: 10.1001/jamaneurol.2013.3646.
9
A genetic model for multimorbidity in young adults.年轻人多种疾病的遗传模型。
Genet Med. 2020 Jan;22(1):132-141. doi: 10.1038/s41436-019-0603-1. Epub 2019 Jul 31.
10
Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome.22q11.2缺失综合征中的拷贝数变异与精神分裂症风险
Hum Mol Genet. 2008 Dec 15;17(24):4045-53. doi: 10.1093/hmg/ddn307. Epub 2008 Sep 20.

引用本文的文献

1
Influence of Polygenic Risk on Height and BMI in Adults With a 22q11.2 Microdeletion.多基因风险对携带22q11.2微缺失的成年人身高和体重指数的影响。
J Endocr Soc. 2025 Jun 28;9(9):bvaf115. doi: 10.1210/jendso/bvaf115. eCollection 2025 Sep.
2
Adipocyte CLDN5 promotes thermogenesis and energy expenditure through regulation of IL10 expression.脂肪细胞CLDN5通过调节IL10表达促进产热和能量消耗。
Nat Commun. 2025 Jul 4;16(1):6151. doi: 10.1038/s41467-025-61371-3.
3
A non-fasting marker of metabolic syndrome in a high-risk population.

本文引用的文献

1
Reciprocal Effects on Neurocognitive and Metabolic Phenotypes in Mouse Models of 16p11.2 Deletion and Duplication Syndromes.16p11.2缺失和重复综合征小鼠模型中神经认知和代谢表型的相互影响。
PLoS Genet. 2016 Feb 12;12(2):e1005709. doi: 10.1371/journal.pgen.1005709. eCollection 2016 Feb.
2
16p11.2 Locus modulates response to satiety before the onset of obesity.16号染色体短臂11.2区域在肥胖症发作前调节饱腹感反应。
Int J Obes (Lond). 2016 May;40(5):870-6. doi: 10.1038/ijo.2015.247. Epub 2015 Dec 1.
3
Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome.
高危人群中代谢综合征的非空腹标志物。
J Nutr Health Aging. 2025 May 8;29(7):100573. doi: 10.1016/j.jnha.2025.100573.
4
DGCR2 targeting affibody molecules for delivery of drugs and imaging reagents to human beta cells.用于将药物和成像试剂递送至人β细胞的靶向DGCR2的亲和体分子。
Sci Rep. 2025 Jan 2;15(1):417. doi: 10.1038/s41598-024-84574-y.
5
Systemic lupus erythematosus in a patient with 22q11.2 deletion syndrome: A case report and review of the literature.一名患有22q11.2缺失综合征患者的系统性红斑狼疮:病例报告及文献复习
Cent Eur J Immunol. 2024;49(3):315-319. doi: 10.5114/ceji.2024.143229. Epub 2024 Nov 8.
6
Real-World Treatment of Schizophrenia in Adults With a 22q11.2 Microdeletion: Traitement dans le monde réel de la schizophrénie chez des adultes atteints du syndrome de microdélétion 22q11.2.22q11.2微缺失成年精神分裂症患者的真实世界治疗:22q11.2微缺失综合征成年患者精神分裂症的真实世界治疗
Can J Psychiatry. 2025 Mar;70(3):160-170. doi: 10.1177/07067437241293983. Epub 2024 Dec 6.
7
Obesity and metabolic syndrome in adults with a 22q11.2 microdeletion.伴有22q11.2微缺失的成年人中的肥胖与代谢综合征
Int J Obes (Lond). 2025 Apr;49(4):642-648. doi: 10.1038/s41366-024-01685-2. Epub 2024 Nov 30.
8
Association between increased BMI and cognitive function in first-episode drug-naïve male schizophrenia.首发未用药男性精神分裂症患者体重指数增加与认知功能之间的关联
Front Psychiatry. 2024 Mar 5;15:1362674. doi: 10.3389/fpsyt.2024.1362674. eCollection 2024.
9
Endocrine manifestations in adults with 22q11.2 deletion syndrome: a retrospective single-center cohort study.22q11.2 缺失综合征成人患者的内分泌表现:一项回顾性单中心队列研究。
J Endocrinol Invest. 2024 Jul;47(7):1827-1836. doi: 10.1007/s40618-023-02276-0. Epub 2024 Feb 3.
10
Preclinical evaluation of Affibody molecule for PET imaging of human pancreatic islets derived from stem cells.用于干细胞来源的人胰岛PET成像的亲和体分子的临床前评估
EJNMMI Res. 2023 Dec 15;13(1):107. doi: 10.1186/s13550-023-01057-3.
22q11.2缺失综合征中线粒体柠檬酸转运体依赖性代谢特征
J Biol Chem. 2015 Sep 18;290(38):23240-53. doi: 10.1074/jbc.M115.672360. Epub 2015 Jul 28.
4
Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms.22q11.2缺失区域的比较图谱及简单模式生物的潜力
J Neurodev Disord. 2015;7(1):18. doi: 10.1186/s11689-015-9113-x. Epub 2015 Jul 1.
5
Fetal growth and gestational factors as predictors of schizophrenia in 22q11.2 deletion syndrome.胎儿生长和妊娠因素作为22q11.2缺失综合征中精神分裂症的预测指标
Genet Med. 2016 Apr;18(4):350-5. doi: 10.1038/gim.2015.84. Epub 2015 Jun 18.
6
Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.抗精神病药、抗抑郁药和心境稳定剂对精神分裂症、抑郁症和双相情感障碍患者身体疾病风险的影响。
World Psychiatry. 2015 Jun;14(2):119-36. doi: 10.1002/wps.20204.
7
Response to clozapine in a clinically identifiable subtype of schizophrenia.氯氮平对精神分裂症临床可识别亚型的反应。
Br J Psychiatry. 2015 Jun;206(6):484-91. doi: 10.1192/bjp.bp.114.151837. Epub 2015 Mar 5.
8
Movement disorders and other motor abnormalities in adults with 22q11.2 deletion syndrome.22q11.2缺失综合征成人的运动障碍及其他运动异常
Am J Med Genet A. 2015 Mar;167A(3):639-45. doi: 10.1002/ajmg.a.36928. Epub 2015 Feb 13.
9
Practical guidelines for managing adults with 22q11.2 deletion syndrome.22q11.2缺失综合征成年患者管理实用指南。
Genet Med. 2015 Aug;17(8):599-609. doi: 10.1038/gim.2014.175. Epub 2015 Jan 8.
10
Growth charts for non-growth hormone treated Prader-Willi syndrome.未经生长激素治疗的普拉德-威利综合征生长图表。
Pediatrics. 2015 Jan;135(1):e126-35. doi: 10.1542/peds.2014-1711. Epub 2014 Dec 8.